EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors

Olga Bobileva iD, Raitis Bobrovs iD, Evelina Elva Sirma, Iveta Kanepe iD, Anna L Bula, Liene Patetko, Anna Ramata-Stunda iD, Solveiga Grinberga, Aigars Jirgensons, Kristaps Jaudzems iD

Molecules · 2023

DOI: 10.3390/molecules28020768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Olga Bobileva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia. Hauptthemen laut MEDLINE: Methyltransferases, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Latvian Council of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 nsp14 guanine-N7-methyltransferase plays an important role in the viral RNA translation process by catalyzing the transfer of a methyl group from S-adenosyl-methionine (SAM) to viral mRNA cap. We report a structure-guided design and synthesis of 3-(adenosylthio)benzoic acid derivatives as nsp14 methyltransferase inhibitors resulting in compound 5p with subnanomolar inhibitory activity and improved cell membrane permeability in comparison with the parent inhibitor. Compound 5p acts as a bisubstrate inhibitor targeting both SAM and mRNA-binding pockets of nsp14. While the selectivity of 3-(adenosylthio)benzoic acid derivatives against human glycine N-methyltransferase was not improved, the discovery of phenyl-substituted analogs 5p,t may contribute to further development of SARS-CoV-2 nsp14 bisubstrate inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesSARS-CoV-2Antiviral AgentsMethylationRNA, MessengerRNA, ViralS-AdenosylmethionineViral Nonstructural Proteins

Stichwörter der Autor:innen

SARS-CoV-2methyltransferase inhibitorsnsp14nsp16

Substanzen

MethyltransferasesRNA, MessengerRNA, ViralS-AdenosylmethionineViral Nonstructural ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
  • Faculty of Biology, University of Latvia, LV-1004 Riga, Latvia.

ORCID-Profile: Olga Bobileva, Raitis Bobrovs, Iveta Kanepe, Anna Ramata-Stunda, Kristaps Jaudzems

Förderung

  • European Regional Development Fund
  • Latvian Council of Science

Zitieren

APA

Bobileva, O., Bobrovs, R., Sirma, E. E., Kanepe, I., Bula, A. L., Patetko, L., Ramata-Stunda, A., Grinberga, S., Jirgensons, A., & Jaudzems, K. (2023). 3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors. Molecules. https://doi.org/10.3390/molecules28020768

Vancouver

Bobileva O, Bobrovs R, Sirma EE, Kanepe I, Bula AL, Patetko L, et al. 3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors. Molecules. 2023. doi:10.3390/molecules28020768

BibTeX
@article{Bobileva2023,
  author = {Bobileva, Olga and Bobrovs, Raitis and Sirma, Evelina Elva and Kanepe, Iveta and Bula, Anna L and Patetko, Liene and Ramata-Stunda, Anna and Grinberga, Solveiga and Jirgensons, Aigars and Jaudzems, Kristaps},
  title = {3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020768}
}
Kostenlos starten →